Charles Schwab’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Buy |
161,967
+8,636
| +6% | +$76.1K | ﹤0.01% | 2778 |
|
|
2025
Q1 | $1.15M | Buy |
153,331
+3,827
| +3% | +$28.7K | ﹤0.01% | 2793 |
|
|
2024
Q4 | $1.25M | Buy |
149,504
+28,148
| +23% | +$235K | ﹤0.01% | 2830 |
|
|
2024
Q3 | $842K | Buy |
121,356
+11,038
| +10% | +$76.6K | ﹤0.01% | 2973 |
|
|
2024
Q2 | $541K | Buy |
110,318
+18,908
| +21% | +$92.6K | ﹤0.01% | 3165 |
|
|
2024
Q1 | $530K | Sell |
91,410
-4,720
| -5% | -$27.4K | ﹤0.01% | 3004 |
|
|
2023
Q4 | $630K | Buy |
96,130
+5,698
| +6% | +$37.3K | ﹤0.01% | 2985 |
|
|
2023
Q3 | $436K | Hold |
90,432
| – | – | ﹤0.01% | 3090 |
|
|
2023
Q2 | $461K | Buy |
90,432
+79,293
| +712% | +$404K | ﹤0.01% | 3091 |
|
|
2023
Q1 | $61.3K | Hold |
11,139
| – | – | ﹤0.01% | 3313 |
|
|
2022
Q4 | $51.1K | Hold |
11,139
| – | – | ﹤0.01% | 3353 |
|
|
2022
Q3 | $70K | Hold |
11,139
| – | – | ﹤0.01% | 3261 |
|
|
2022
Q2 | $50K | Sell |
11,139
-65,098
| -85% | -$292K | ﹤0.01% | 3393 |
|
|
2022
Q1 | $384K | Hold |
76,237
| – | – | ﹤0.01% | 3156 |
|
|
2021
Q4 | $665K | Buy |
76,237
+4,505
| +6% | +$39.3K | ﹤0.01% | 3060 |
|
|
2021
Q3 | $670K | Hold |
71,732
| – | – | ﹤0.01% | 3037 |
|
|
2021
Q2 | $920K | Buy |
+71,732
| New | +$920K | ﹤0.01% | 2962 |
|